RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-80926

Recombinant Monoclonal Antibody
Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

Immunocytochemistry/ Immunofluorescence, Western Blot

Label

Unconjugated

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # 1312D

Format

Azide and BSA Free

Concentration

1 mg/ml

View all RIPK3/RIP3 Antibodies »

Product Specifications

Immunogen

RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free was made to a partial synthetic peptide made to an internal portion of the human RIPK3/RIP3 protein (between amino acids 470-540). This seqeunce has 100% homology to isoform CRA_a and isoform CRA_b.

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Theoretical MW

56.7 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Scientific Data Images for RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free

Immunocytochemistry/ Immunofluorescence: RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free [NBP2-80926]

Immunocytochemistry/ Immunofluorescence: RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free [NBP2-80926]

Immunocytochemistry/Immunofluorescence: RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free [NBP2-80926] - RIPK3/RIP3 was detected in immersion fixed SK-BR-3 human breast cancer cell line (positive stain) and HepG2 human human hepatocellular carcinoma cell line (negative stain) using Rabbit Monoclonal Anti-Human RIPK3/RIP3 Antibody [NBP2-76799] at 1 ug/mL for 3 hours at room temperature. Cells were stained using the NorthernLights 557-conjugated Anti-Rabbit IgG Secondary Antibody (red; [NL004]) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. Image from the standard format of this antibody.

Applications for RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

5 - 15 ug/ml

Western Blot

2 ug/ml

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Formulation

PBS

Format

Azide and BSA Free

Preservative

No Preservative

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: RIPK3/RIP3

RIPK3, Receptor interacting serine/threonine kinase 3 or RIP-like protein kinase 3 (human RIPK3 isoform1 theoretical molecular weight 57kDa) is a cytosolic protein with an amino terminal active kinase domain. RIP kinases, RIPK1 and RIPK3 play a central role in the induction of necroptosis, a form of programmed and inflammatory cell death that is caspase-independent (1). Necroptosis is a form of programmed necrosis which is initiated through the activation of RIPK3 by various ligands such as Fas, LPS and TNF. Formation of the necrosome results from the interaction between RIPK1 and RIPK3 mediated through their RIP homotypic interaction motifs (RHIMs) (1, 2). Following necrosome formation, RIPK3 activation leads to the phosphorylation of mixed lineage kinase domain-like protein (MLKL) which induces its oligomerization and translocation to the cell membrane where it alters plasma membrane integrity (2). Loss of membrane integrity results in lytic cell death, release of damage associated molecular patterns (DAMPs) and inflammation (2, 3). Therefore, the interaction of RIPK3 with other RHIM proteins is necessary for the initiation of necroptosis, while the execution phase is dependent on the activation of MLKL (4).

RIPK3 has several phosphorylation sites that are required for its role in necroptosis. For example, serine204 in mouse, which is conserved in the human (serine199), is necessary for necroptosis while serine residues 232 and 227 are both required for RIPK3s interaction with MLKL (2). The core necroptosis proteins RIPK1/RIPK3 and MLKL are implicated in several disease states such as neurodegeneration, cardiovascular, hepatic and pulmonary disease (3).

References

1. Orozco, S., & Oberst, A. (2017). RIPK3 in cell death and inflammation: the good, the bad, and the ugly. Immunological Reviews. https://doi.org/10.1111/imr.12536

2. Dhuriya, Y. K., & Sharma, D. (2018). Necroptosis: A regulated inflammatory mode of cell death. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-018-1235-0

3. Choi, M. E., Price, D. R., Ryter, S. W., & Choi, A. M. K. (2019). Necroptosis: A crucial pathogenic mediator of human disease. JCI Insight. https://doi.org/10.1172/jci.insight.128834

4. Lee, K.-H., & Kang, T.-B. (2019). The Molecular Links between Cell Death and Inflammasome. Cells. https://doi.org/10.3390/cells8091057

Long Name

Receptor (TNFRSF)-Interacting Serine-Threonine Kinase 3

Alternate Names

RIP3

Gene Symbol

RIPK3

Additional RIPK3/RIP3 Products

Product Documents for RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Download SDS

Product Specific Notices for RIPK3/RIP3 Antibody (1312D) - Azide and BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.